AVITA Medical, Inc. (NASDAQ:RCEL) Just Reported And Analysts Have Been Lifting Their Price Targets [Yahoo! Finance]
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
Revenues of US$50m came in 2.3% below estimates, but statutory losses were slightly better than expected, at US$1.46 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We thought readers would find it interesting to see the analysts latest (statutory) post-earnings forecasts for next year. View our latest analysis for AVITA Medical Taking into account the latest results, the current consensus from AVITA Medical's ten analysts is for revenues of US$80.4m in 2024. This would reflect a sizeable 60% increase on its revenue over the past 12 months. Losses are supposed to decline, shrinking 15% from last year to US$1.17. Before this earnings announcement, the analysts had been modelling revenues of US$77.7m and losses of US$1.28 per share in 2024. It looks like there's been a modest increase in sentiment in the recent update
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical: Financial Challenges Ahead, Despite Innovative RECELL Device [Seeking Alpha]Seeking Alpha
- AVITA Medical to Host Investor Webinar BriefingGlobeNewswire
- AVITA Medical, Inc. (NASDAQ: RCEL) had its "neutral" rating re-affirmed by analysts at Piper Sandler. They now have a $9.00 price target on the stock, down previously from $21.00.MarketBeat
- AVITA Medical, Inc. (NASDAQ: RCEL) had its price target lowered by analysts at Cantor Fitzgerald from $22.00 to $21.00. They now have an "overweight" rating on the stock.MarketBeat
- AVITA Medical Reports First Quarter Financial Results [Yahoo! Finance]Yahoo! Finance
RCEL
Earnings
- 5/13/24 - Miss
RCEL
Sec Filings
- 5/13/24 - Form 10-Q
- 5/13/24 - Form 8-K
- 4/23/24 - Form DEF
- RCEL's page on the SEC website